Arun Swaminathan's most recent trade in Coya Therapeutics Inc was a trade of 240,964 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Coya Therapeutics Inc | Arun Swaminathan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 240,964 | 240,964 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Arun Swaminathan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.36 per share. | 13 Nov 2024 | 5,000 | 10,000 | - | 7.4 | 36,797 | Common Stock, par value $0.0001 per share |
Coya Therapeutics Inc | Arun Swaminathan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.34 per share. | 11 Nov 2024 | 5,000 | 5,000 | - | 7.3 | 36,689 | Common Stock, par value $0.0001 per share |